Uterine Carcinosarcoma
What's New
Last Posted: Dec 07, 2023
- Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
Dimitrios Nasioudis et al. Gynecol Oncol 2023 1801-5 - Immunological Role of TP53 Somatic Mutation Classification in Human Cancers.
Fang Jianfei, et al. Journal of oncology 2023 0 1904309 - Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
Liu Yihua, et al. Gynecologic oncology 2018 0 (2) 243-249 - Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi Muhammad Asif, et al. Asian Pacific journal of cancer prevention : APJCP 2020 0 (11) 3199-3209 - Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
Ashley Charles W, et al. Histopathology 2021 0 (2) 176-186 - Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer.
Luo Zhiwen, et al. Frontiers in pharmacology 2022 0 1053137 - Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer.
Vasuki K Archana, et al. Applied biochemistry and biotechnology 2021 0 (1) 407-433 - Mutational landscape implicates epithelial-mesenchymal transition gene TGF-?2 mutations for uterine carcinosarcoma after adjuvant tamoxifen therapy for breast carcinoma.
Shen Ling, et al. International journal of clinical and experimental pathology 2020 0 (3) 996-1002 - TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Travaglino Antonio, et al. Pathology oncology research : POR 2020 5 - Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.
Hembree Timothy N, et al. Cancer control : journal of the Moffitt Cancer Center 2016 1 (1) 61-6
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: